Research never stops

Archive



May 22, 2017

Evotec receives pre-clinical milestone as part of its Endometriosis Alliance with Bayer

Hamburg, Germany, 22 May 2017:
Evotec AG announced today that its multi-target endometriosis alliance with Bayer has reached another significant pre-clinical milestone, triggering a payment of approx. EUR 5 m to Evotec for the transition of a programme into pre-clinical development for the treatment of endometriosis.

- read more
May 10, 2017

Evotec announces first quarter results 2017 and corporate update

Hamburg, Germany, 10 May 2017: Evotec AG today reported financial results and corporate updates for the first quarter of 2017.

- read more
Apr 05, 2017

Evotec achieves first milestone in Diabetes alliance with Sanofi

Hamburg, Germany 05 April 2017: Evotec AG today announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached an important milestone, triggering a payment of EUR 3.0 m to Evotec, for achieving pre-clinical proof-of-concept.

- read more
Mar 31, 2017

EvotecĀ“s partner Forge Therapeutics receives prestigious Carb-X research award

Mar 28, 2017

Evotec fiscal year results 2016: Leading innovation efficiency & First-in-class drug discovery

Mar 03, 2017

Great story - Short film

Please click here and enjoy.

- read more
Feb 21, 2017

Evotec AG: 'LAB282' awarded first projects

Feb 09, 2017

Novo A/S becomes new long-term strategic shareholder in Evotec

Jan 26, 2017

Cyprotex, an Evotec company, expands into new UK facility at Alderley Park

Jan 19, 2017

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma (Japan)

Jan 17, 2017

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics

Jan 12, 2017

HaplogenĀ“s novel antiviral target partnered with Evotec published in 'Nature'

Jan 09, 2017

Evotec and Eternygen to develop novel metabolic disease therapy